AUA 2017 BPH

AUA 2017: Urological Association of Asia (UAA) Lecture: A Critical Look at Surgical Options for BPH

Boston, MA (UroToday.com) This presentation by Dr. Kirpekar was to discuss the changes on the horizon regarding benign prostatic hyperplasia (BPH) surgery. Dr. Kirpekar noted that there have been major conceptual changes in the treatment of BPH over the years, with transurethral enucleation of the prostate (TUEP) taking preference over TURP,

AUA 2017: WATER Study Clinical Results – Phase III Double-blind Randomized Control Trial of Aquablation vs. Transurethral Resection of the Prostate for Moderate-to-Severe Benign Prostatic Hyperplasia

Boston, MA (UroToday.com) This late-breaking abstract was presented to report the results of the Phase III double-blind RCT of a comparison between the use of aquablation (or water stream to ablate/resect) for prostate resection and the standard-of-care transurethral resection of the prostate (TURP).

AUA 2017: Robotic Simple Prostatectomy: The USC Experience

Boston, MA (UroToday.com) Dr. Carlos Fay from the University of Southern California, (USC), presented data on the institution’s experience with robotic simple prostatectomy. As an introduction to his talk, Dr. Fay explained that although open simple prostatectomy has been the traditional approach it is however associated with significant risk for complications.

AUA 2017: Thulium Laser Vaporesection of the Prostate and Bipolar Transurethral Resection of the Prostate in Patients With Benign Prostatic Hyperplasia – Single Center Prospective Randomized Study

Boston, MA (UroToday.com) Benign prostatic hyperplasia (BPH), where the prostate glad is enlarged, has been commonly treated using laser surgery such as the transurethral resection. More recently, the thulium laser was in-troduced as another option. This study aims to compare the safety and effectiveness of the thulium laser vaporesections of the prostate (ThuVaRP) compared to the bipolar transurethral resection of the prostate (TURP).

AUA 2017: 5 Year Prospective, Randomized, Controlled Study Results on the Minimally Invasive Prostatic Urethral Lift (PUL)

Boston, MA (UroToday.com) Secondary to benign prostatic hyperplasia, the Prostatic Uretheral Lift (PUL) has been shown to rapidly reduce lower urinary tract symptoms (LUTS) with minimal side effects. PUL is currently the only mechanical device that is available without any type of heat applica-tion to treat BPH. This data presented is the end of the PUL study which was presented 5 years ago.

AUA 2017: How Long Should Patients Wait Before Resuming Sexual Activity After BPH Surgery?

Boston, MA (UroToday.com) Surgical therapy for benign prostatic hyperplasia (BPH) is amongst the most common urological procedures. While most patients are expected to resume sexual activity postoperatively, data pertaining to the required time of abstinence is lacking. A traditional 6 week period of abstinence from any kind of sexual activity is recommended after BPH surgeries in many centers.

AUA 2017: B-Mode Ultrasound Assessment of Penile Corporal Heterogeneity Correlates to Ultrafast™ Doppler Quantification of End Diastolic Velocity (EDV) in Men with Erectile Dysfunction (ED): Foundation for Algorithmic Assessment of Penile Fibrosis

Boston, MA (UroToday.com) Corporal fibrosis is a common etiology in patients with erectile dysfunction (ED). Among the available imaging modalities to evaluate ED, ultrasound (US) is used to measure the end diastolic velocity (EDV) of the penile corporal artery to characterize the extent and establish a threshold of disease.

Page 1 of 2

AUA 2017 BPH

Free Daily and Weekly newsletters offered by content of interest

Login